ADALUZIS Trademark

Trademark Overview

On Tuesday, February 25, 2020, a trademark application was filed for ADALUZIS with the United States Patent and Trademark Office. The USPTO has given the ADALUZIS trademark a serial number of 88809725. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, August 14, 2023. This trademark is owned by Basilea Pharmaceutica AG. The ADALUZIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases
adaluzis

General Information

Serial Number88809725
Word MarkADALUZIS
Filing DateTuesday, February 25, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, August 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBasilea Pharmaceutica AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4058
CH

Trademark Events

Event DateEvent Description
Tuesday, August 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2023SOU EXTENSION 5 GRANTED
Tuesday, August 8, 2023SOU EXTENSION 5 FILED
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2023SOU EXTENSION 4 GRANTED
Monday, February 27, 2023SOU EXTENSION 4 FILED
Monday, February 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 5, 2022SOU EXTENSION 3 GRANTED
Monday, September 5, 2022SOU EXTENSION 3 FILED
Monday, September 5, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, February 20, 2022SOU EXTENSION 2 GRANTED
Sunday, February 20, 2022SOU EXTENSION 2 FILED
Sunday, February 20, 2022SOU TEAS EXTENSION RECEIVED
Saturday, October 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 15, 2021SOU EXTENSION 1 GRANTED
Thursday, September 9, 2021SOU EXTENSION 1 FILED
Tuesday, October 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 30, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, September 29, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, September 29, 2021PETITION TO REVIVE-GRANTED
Wednesday, September 29, 2021TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 13, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 13, 2020NON-FINAL ACTION WRITTEN
Wednesday, May 13, 2020ASSIGNED TO EXAMINER
Friday, February 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 28, 2020NEW APPLICATION ENTERED

Related Keywords

adaluzis treatment diseases gastrointestinal neurological oncological cardiovascular gynecological dermatological preparations substances